Therapeutics

Pioneering mitochondrial transfer regulation to treat age-related diseases.

Molecular glue therapeutics platform combining AI, physics and chemistry for hard-to-drug oncology targets.

Novel medicines to treat pain and itch.

First-in-class therapeutics for reprogramming heart disease.

An interventional medical device preventing the recurrence of Glioblastoma.

Precision antibody therapeutics to treat patients with resistant cancers who have exhausted existing treatment options.

Developing cutting-edge exosome-based solutions to tackle cancer and advance the future of immuno-oncology.

Therapeutic platform targeting astrocytic networks to develop novel disease-modifying treatments for Parkinson’s and other complex brain disease.

Delivering safer, simpler, faster mRNA therapies for rare and complex disease, enabled by AI.